These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25751007)

  • 1. Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications.
    Alvarez-Cubero MJ; Vázquez-Alonso F; Puche-Sanz I; Ortega FG; Martin-Prieto M; Garcia-Puche JL; Pascual-Geler M; Lorente JA; Cozar-Olmo JM; Serrano MJ
    Curr Drug Targets; 2016; 17(6):693-701. PubMed ID: 25751007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
    Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
    J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
    Quayle L; Ottewell PD; Holen I
    Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.
    Pavese JM; Bergan RC
    Cancer Lett; 2014 Oct; 352(2):179-86. PubMed ID: 25016063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
    Chistiakov DA; Chekhonin VP
    Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients.
    Worroll D; Galletti G; Gjyrezi A; Nanus DM; Tagawa ST; Giannakakou P
    Phys Biol; 2019 Mar; 16(3):036003. PubMed ID: 30763921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
    Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
    Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
    [No Abstract]   [Full Text] [Related]  

  • 11. Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance.
    Hariri A; Mirian M; Khosravi A; Zarepour A; Iravani S; Zarrabi A
    Drug Resist Updat; 2024 Sep; 76():101119. PubMed ID: 39111134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.
    Yang L; Lv Z; Xia W; Zhang W; Xin Y; Yuan H; Chen Y; Hu X; Lv Y; Xu Q; Weng X; Ni C
    Clin Transl Oncol; 2018 Jul; 20(7):912-921. PubMed ID: 29243075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
    Horimoto Y; Tokuda E; Murakami F; Uomori T; Himuro T; Nakai K; Orihata G; Iijima K; Togo S; Shimizu H; Saito M
    J Transl Med; 2018 Oct; 16(1):287. PubMed ID: 30342534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
    Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
    Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated tumor cells and dormancy in prostate cancer metastasis.
    van der Toom EE; Verdone JE; Pienta KJ
    Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating tumor cells: a new challenge for laboratory medicine].
    Séronie-Vivien S
    Ann Biol Clin (Paris); 2014; 72(2):153-77. PubMed ID: 24736136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of circulating tumor cells and the available capture tools (Review).
    Guan Y; Xu F; Tian J; Chen H; Yang C; Huang S; Gao K; Wan Z; Li M; He M; Chong T
    Oncol Rep; 2020 May; 43(5):1355-1364. PubMed ID: 32323847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.